Sustained-release and immediate-release tablets of Emblica officinalis have been developed to provide a controlled release of the active ingredients over an extended period of time. The sustained-release tablets are designed to release the active ingredients gradually, ensuring a consistent level of the compound in the bloodstream over several hours. The immediate-release tablets, on the other hand, release the active ingredients quickly, providing a rapid onset of action. The abstract of a study on sustained and immediate-release tablets of Emblica officinalis would summarize the research findings, including the method of preparation, the physicochemical properties of the tablets, and the in vitro and in vivo release characteristics. It may also include information on the pharmacokinetic profile of the tablets, their safety and tolerability, and their potential therapeutic applications.